Pfizer Collaborates with Centogene to Access its Rare Disease Data

Shots:

• Centogene to receive up front and will be eligible for additional research payments for any future collaboration. Pfizer to get access to CENTOGENE’s data repository, which may be used to discover and validate new therapies targeting rare diseases
• The companies will work together in mining the data repository and jointly agree for any research project to substantiate the results of data mining. Pfizer along with international data privacy regulations will manage, protect & share individual-level data from the repository
• Centogene’s rare disease data repository includes relevant structured and unstructured patient data, including clinical information; health records; and genetic, transcriptomic, proteomic, and metabolomic data

Click here to­ read full press release/ article | Ref: GlobeNewswire | Image: Daily Herald